Science Explorer Back to mapMap
Discussion
Hospital / health system · Toulouse · France

Institut Claudius Regaud

In research, Institut Claudius Regaud stands highest in Health Sciences (#2,057 of 9,902 worldwide) and Medicine (#2,035 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology (Oncology is 14.4× its share of world research).

eng.claudiusregaud.frROR OpenAlex
World rank, 2022-now
#12,257
of 22,385 · #7,564 all time
Rank in France
#280
of 517
Research works
1.2k
◆ 0% vs 2018-21
Citations
29k
25.0 per fractional work
Top-10% rate
9.7%
all institutions 10.0%
vs its own fields
1.05×
1.00× is exactly expected
Open access
23%
world 40%
International
18%
world 18%
Institut Claudius Regaud

What is Institut Claudius Regaud known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #2,057 of 9,902 10.1%121 #2420
MedicineField #2,035 of 8,541 10.0%115 #2289

Each strip is that field's whole ranked pool, with the notch where Institut Claudius Regaud sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Institut Claudius Regaud work in?

In 2022-now, 80% of research at Institut Claudius Regaud is in Health Sciences, 13% in Life Sciences. Its largest fields are Medicine (76%), Biochemistry, Genetics and Molecular Biology (10%), Health Professions (3%). It does 3.3× the world's share of Health Sciences.

Health Sciences: 144 fractional works · 79.7% of its workMedicine: 138 fractional works · 76.2% of its workOncology: 29 fractional works · 16.2% of its workSurgery: 20 fractional works · 10.9% of its workPulmonary and Respiratory Medicine: 19 fractional works · 10.8% of its workReproductive Medicine: 9 fractional works · 5.2% of its workRadiology, Nuclear Medicine and Imaging: 8 fractional works · 4.5% of its workObstetrics and Gynecology: 8 fractional works · 4.3% of its workEpidemiology: 6 fractional works · 3.4% of its workDermatology: 5 fractional works · 3.0% of its workPathology and Forensic Medicine: 4 fractional works · 2.3% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 2.0% of its workOtorhinolaryngology: 3 fractional works · 1.9% of its workGenetics: 3 fractional works · 1.6% of its workHepatology: 2 fractional works · 1.2% of its workPhysiology: 2 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 1.0% of its workAnesthesiology and Pain Medicine: 2 fractional works · 0.9% of its workRheumatology: 2 fractional works · 0.8% of its workHematology: 1 fractional works · 0.8% of its workNeurology: 1 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.5% of its workPsychiatry and Mental health: 1 fractional works · 0.5% of its workUrology: 1 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.4% of its workEmergency Medicine: 1 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.9% of its workHealth Professions: 5 fractional works · 2.8% of its workGeneral Health Professions: 4 fractional works · 2.0% of its workOccupational Therapy: 1 fractional works · 0.4% of its workEmergency Medical Services: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 1 fractional works · 0.7% of its workPeriodontics: 1 fractional works · 0.4% of its workOral Surgery: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.0% of its workLife Sciences: 24 fractional works · 13.4% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 10.0% of its workCancer Research: 8 fractional works · 4.2% of its workMolecular Biology: 5 fractional works · 2.9% of its workGenetics: 4 fractional works · 2.4% of its workSmaller subfields together: 1 fractional works · 0.5% of its workImmunology and Microbiology: 4 fractional works · 2.1% of its workImmunology: 4 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 0.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 8 fractional works · 4.3% of its workPhysics and Astronomy: 3 fractional works · 1.5% of its workRadiation: 2 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 2 fractional works · 1.0% of its workStatistics and Probability: 2 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 1 fractional works · 0.7% of its workBiomedical Engineering: 1 fractional works · 0.7% of its workComputer Science: 1 fractional works · 0.5% of its workArtificial Intelligence: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.2% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.0% of its workSocial Sciences: 5 fractional works · 2.6% of its workSocial Sciences: 2 fractional works · 0.9% of its workSociology and Political Science: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.8% of its workEconomics and Econometrics: 1 fractional works · 0.8% of its workPsychology: 1 fractional works · 0.6% of its workClinical Psychology: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.2% of its workALL ITS WORKInstitut ClaudiusRegaud181fractional works, 2022-now
Life Sciences13%Physical Sciences4%Health Sciences80%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine13876.2%
    2. Health Professions52.8%
    3. Dentistry10.7%
    4. Nursing00.0%
    1. Biochemistry, Genetics and Molecular Biology1810.0%
    2. Immunology and Microbiology42.1%
    3. Pharmacology, Toxicology and Pharmaceutics10.7%
    4. Neuroscience10.6%
    5. Agricultural and Biological Sciences00.1%
    1. Physics and Astronomy31.5%
    2. Mathematics21.0%
    3. Engineering10.7%
    4. Computer Science10.5%
    5. Environmental Science10.3%
    6. Chemistry00.2%
    7. Materials Science00.0%
    8. Chemical Engineering00.0%
    1. Social Sciences20.9%
    2. Economics, Econometrics and Finance10.8%
    3. Psychology10.6%
    4. Decision Sciences00.2%
    5. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Institut Claudius Regaud specialise in?

Where its research is concentrated relative to its size: Oncology takes 14.4× the share of its output that it takes of world research.

  1. OncologySubfield · 29.3 works14×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.87× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 2.07× its world share, 4 worksImmunology and Micro…Neuroscience: 0.34× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.91× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.05× its world share, 0 worksChemical EngineeringChemistry: 0.14× its world share, 0 worksChemistryComputer Science: 0.06× its world share, 1 worksComputer ScienceEngineering: 0.05× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 0.84× its world share, 2 worksMathematicsPhysics and Astronomy: 0.67× its world share, 3 worksPhysics and AstronomyDentistry: 1.51× its world share, 1 worksDentistryHealth Professions: 1.06× its world share, 5 worksHealth ProfessionsMedicine: 3.96× its world share, 138 worksMedicineNursing: 0.09× its world share, 0 worksNursingDecision Sciences: 0.18× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.38× its world share, 2 worksEconomics, Econometr…Psychology: 0.21× its world share, 1 worksPsychologySocial Sciences: 0.07× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Medicine3.96×138 works
  2. Immunology and Microbiology2.07×4 works
  3. Pharmacology, Toxicology and Pharmaceutics1.91×1 works
  4. Biochemistry, Genetics and Molecular Biology1.87×18 works
  5. Dentistry1.51×1 works
  6. Health Professions1.06×5 works
  7. Mathematics0.84×2 works
  8. Physics and Astronomy0.67×3 works
  9. Economics, Econometrics and Finance0.38×2 works
  10. Neuroscience0.34×1 works
  11. Psychology0.21×1 works
  12. Decision Sciences0.18×0 works
  13. Chemistry0.14×0 works
  14. Nursing0.09×0 works
  15. Environmental Science0.07×1 works
  16. Social Sciences0.07×2 works
  17. Computer Science0.06×1 works
  18. Chemical Engineering0.05×0 works
  19. Engineering0.05×1 works
  20. Agricultural and Biological Sciences0.02×0 works
  21. Materials Science0.01×0 works

Who are the top researchers at Institut Claudius Regaud?

Ranked on the quality score, Christine Chevreau, Jean‐Pierre Delord and Carlos Gomez‐Roca lead among researchers whose main affiliation is Institut Claudius Regaud.

  1. 1 Christine Chevreau France · #84,115 worldwide 29k citations · 492 works
  2. 2 Jean‐Pierre Delord France · #98,440 worldwide 24k citations · 501 works
  3. 3 Carlos Gomez‐Roca France · #134,741 worldwide 7k citations · 427 works
  4. 4 Magali Lacroix‐Triki France · #140,974 worldwide 11k citations · 258 works
  5. 5 Florence Dalenc France · #155,631 worldwide 17k citations · 570 works
  6. 6 Denis Querleu France · #242,412 worldwide 25k citations · 573 works
  7. 7 Damien Pouessel France · #321,395 worldwide 5.3k citations · 235 works
  8. 8 Thomas Filleron France · #513,586 worldwide 12k citations · 550 works
  9. 9 Laurence Gladieff France · #521,981 worldwide 10k citations · 352 works
  10. 10 Eliane Mery-Lamarche France · #599,690 worldwide 3.3k citations · 214 works
All ranked researchers at Institut Claudius Regaud

What are the most cited papers from Institut Claudius Regaud?

The most cited paper from Institut Claudius Regaud is "FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer" (Thierry Conroy, Françoise Desseigne, Marc Ychou et al., 2011), with 7,927 citations. Next come "Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma" (4,813) and "Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study" (3,072).

Most cited papers
#PaperReleasedCitations
1 FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine Open access 11 May 2011 7,927
2 Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Bernard J. Escudier, Tim G Eisen, Walter Michael Stadler et al. · New England Journal of Medicine Open access 10 Jan 2007 4,813
3 Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study Aurélien Marabelle et al. · Journal of Clinical Oncology Open access 4 Nov 2019 3,072
4 Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study Aurélien Marabelle et al. · The Lancet Oncology Open access 10 Sep 2020 2,600
5 Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group Antonio Pierangelo Palumbo et al. · Journal of Clinical Oncology Open access 3 Aug 2015 2,243
All 60 most cited papers, with filters and sorting

Which keywords describe research at Institut Claudius Regaud?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Radiotherapy, Clinical Trials, Immunotherapy, Metastasis, Biomarkers and Survival Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy32▲ 25×22 topics
  2. Clinical Practice Guidelines16▲ 17×9 topics
  3. Radiotherapy16▲ 22×13 topics
  4. Clinical Trials15▲ 12×11 topics
  5. Immunotherapy13▲ 10×14 topics
  6. Biomarkers13▲ 10×10 topics
  7. Metastasis13▲ 21×10 topics
  8. Epidemiology13▲ 1.80×39 topics
  9. Survival Analysis13▲ 26×7 topics
  10. Quality of Life12▲ 4.8×21 topics
  11. Prognostic Factors11▲ 14×14 topics
  12. Breast Cancer10▲ 22×11 topics
  13. Cytoreductive Surgery10▲ 85×2 topics
  14. Ovarian Cancer10▲ 59×3 topics
  15. Neoadjuvant Therapy9▲ 22×5 topics
  16. Genomic Analysis9▲ 19×4 topics
  17. Molecular Classification9▲ 31×4 topics
  18. Tumor Microenvironment8▲ 10×7 topics
  19. Targeted Therapy8▲ 21×5 topics
  20. Mutation Analysis8▲ 61×1 topic
  21. Tumor Models8▲ 77×1 topic
  22. Molecular Subtypes8▲ 49×3 topics
  23. Cancer8▲ 3.1×26 topics
  24. Precision Medicine7▲ 7.8×6 topics
  25. Management7▲ 4.6×13 topics
  26. Metastatic Breast Cancer7▲ 62×2 topics
  27. Genetic Mutations6▲ 8.2×11 topics
  28. Cervical Cancer6▲ 31×3 topics
  29. Cetuximab6▲ 40×2 topics
  30. Radiation Therapy6▲ 23×5 topics
  31. Immune Checkpoint Blockade6▲ 27×1 topic
  32. PD-1 and PD-L16▲ 27×1 topic
  33. Sentinel Lymph Node Biopsy6▲ 36×2 topics
  34. Molecular Characterization6▲ 17×4 topics
  35. Robotic Surgery6▲ 20×5 topics
  36. Survival5▲ 21×4 topics
  37. Chemoradiotherapy5▲ 53×2 topics
  38. Brachytherapy5▲ 64×1 topic
  39. Endometrial Carcinoma5▲ 64×1 topic
  40. Prognostic Markers5▲ 24×3 topics

Which research topics does Institut Claudius Regaud publish most on?

By volume in 2022-now: Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, Endometrial and Cervical Cancer Treatments and Breast Cancer Treatment Studies.

Ovarian cancer diagnosis and treatment: 8 fractional worksCancer Immunotherapy and Biomarkers: 6 fractional worksEndometrial and Cervical…5Endometrial and Cervical Cancer Treatments: 5 fractional worksBreast Cancer Treatment …4Breast Cancer Treatment Studies: 4 fractional worksAdvanced Breast Cancer Therapies: 4 fractional worksColorectal Cancer Treatments and Studies: 3 fractional worksHead and Neck Cancer Stu…3Head and Neck Cancer Studies: 3 fractional worksCancer Treatment and Pharmacology: 3 fractional worksLung Cancer Treatments and Mutations: 2 fractional worksSarcoma Diagnosis and Treatment: 2 fractional works
Reproductive MedicineOncologyObstetrics and GynecologyCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 8 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 6 works
  3. 3 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 5 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 4 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 3 works
  7. 7 Head and Neck Cancer Studies Otorhinolaryngology 3 works
  8. 8 Cancer Treatment and Pharmacology Oncology 3 works
  9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  10. 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.2%not open76.8%

World: 40% of research is openly available.

with international co-authors18.5%domestic only81.5%

World: 18% is written across borders.

How has Institut Claudius Regaud's research output changed?

Output in 2022-2025 was 0% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Institut Claudius Regaud as a percentage of every work published that year, 0.00076% in 2024.

still counting0.0010%0.0020%0.0030%Institut Claudius Regaud0.00066% in 202519801990200020102020

Fractional works of Institut Claudius Regaud over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%all institutions10.0% in 2025Institut Claudius Regaud7.8% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 21.7% in 2017.

Other research institutions in Toulouse

All research institutions in Toulouse

Share Institut Claudius Regaud's ranking

Institut Claudius Regaud on Science Explorer

A card with Institut Claudius Regaud's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Institut Claudius Regaud. Posts are plain text and can be reported.